ICN to Split Stock, Names Board Member
(Bloomberg News)
COSTA MESA —
ICN Pharmaceuticals Inc. said it plans a 2-for-1 split in its shares and will raise its divided 12.5% to 36 cents a year.
The stock split will take effect March 16 for holders of record Feb. 17. This is ICN’s fifth consecutive annual dividend increase. It will be adjusted for the stock split.
The drug manufacturer also said it appointed Andrei Kozyrev, a former Russian minister of foreign affairs, to its board. ICN already is one of the largest drug makers in Russia and is expanding its Eastern Europe operations.
